Hydrolysis of myelin basic protein by IgM and IgA antibodies from the sera of patients with multiple sclerosis

Medical Science Monitor

Volumn 11, Issue 8, 2005, Pages

  Polosukhina, Dar'ya I ^a   Buneva, Valentina N ^a   Doronin, Boris M ^b   Tyshkevich, Olga B ^b   Boiko, Alexey N ^c   Gusev, Evgenii I ^c   Favorova, Olga O ^c   Nevinsky, Georgy A ^a  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^b NOVOSIBIRSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^c PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Abzymes; Autoimmunity; Human serum; Hydrolysis of myelin basic protein; IgG, IgM, IgA; Multiple sclerosis

Indexed keywords

AUTOANTIGEN; BENZAMIDINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MYELIN; MYELIN BASIC PROTEIN; POLYCLONAL ANTIBODY; PROTEOLIPID; SERINE PROTEINASE;

ADULT; ANTIBODY SCREENING; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; CLINICAL ARTICLE; DEMYELINATION; ENZYME ACTIVITY; FEMALE; HUMAN; HYDROLYSIS; IMMUNE SYSTEM; MALE; MULTIPLE SCLEROSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEGRADATION;

ADOLESCENT; ADULT; ANIMALS; CHROMATOGRAPHY, GEL; FEMALE; HUMANS; HYDROLYSIS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; SWINE;

EID: 24044445523     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Suzuki H: Recent advances in abzyme studies. J Biochem, 1994; 115: 623-28
2. Tramontano A, Gololobov G, Paul S: Proteolytic antibodies: origins, selection and induction. Chem Immunol, 2000; 77: 1-17
3. Gololobov G, Tramontano A, Paul S: Nucleophilic proteolytic antibodies. Appl Biochem Biotechnol, 2000; 83: 221-31
4. Nevinsky GA, Semenov DV, Buneva VN: Catalytic antibodies (abzymes) induced by stable transition-state analogs. Biochemistry (Moscow), 2000; 65: 1459-72
5. Nevinsky GA, Kanyshkova TG, Buneva VN: Natural catalytic antibodies (abzymes) in normalcy and pathology. Biochemistry (Moscow), 2000; 65: 1245-55
6. Nevinsky GA, Favorova OO, Buneva, VN: Natural Catalytic Antibodies - New Characters in the Protein Repertoire. In: E. Golemis, editor. Protein-protein interactions; a molecular cloning manual. Cold Spring Harbor, 2002; 523-34
7. Nevinsky GA, Buneva VN: Human catalytic RNA- and DNA-hydrolyzing antibodies, J Immunol Methods, 2002; 269: 235-45
8. Nevinsky GA, Buneva VN: Catalytic antibodies in healthy humans and patients with autoimmune and viral pathologies. J Cell Mol Med, 2003; 7: 265-76
9. Paul S, Volle DJ, Beach CM et al: Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science, 1989; 244: 1158-61
10. Shuster AM, Gololobov GV, Kvashuk OA et al: DNA hydrolyzing autoantibodies. Science, 1992; 256: 665-67
11. Buneva VN, Andrievskaya OA, Romannikova IV et al: Interaction of catalytically active antibodies with oligoribonucleotides. Mol Biol (Moscow), 1994; 28: 738-43
12. Andrievskaya OA, Buneva VN, Baranovskii AG et al: Catalytic diversity of polyclonal RNA-hydrolyzing IgG antibodies from the sera of patients with lupus erythematosus. Immunol Lett, 2002; 81: 191-98
13. Vlassov AV, Baranovskii AG, Kanyshkova TG et al: Substrate specificity of DNA- and RNA-hydrolyzing antibodies from blood of patients with polyarthritis and Hashimoto's thyroiditis. Mol Biol (Moscow), 1998; 32: 559-69
14. Baranovskii AG, Matyushin VG, Vlassov AV et al: DNA- and RNA-hydrolyzing antibodies from blood of patients with various forms of viral hepatitis. Biochemistry (Moscow), 1997; 62: 1358-66
15. Kozyr AV, Kolesnikov A, Aleksandrova ES et al: Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases. Appl Biochem Biotechnol, 1998; 75: 45-61
16. Gololobov GV, Mikhalap SV, Starov AV et al: Natural targets for DNA-hydrolyzing antibodies. Appl Biochem Biotechnol, 1994; 47: 305-14
17. Savel'ev AN, Eneyskaya EV, Shabalin KA et al: Antibodies with amylolytic activity. Protein Peptide Lett, 1999; 6: 179-84
18. Neustoev KN, Ivanen DR, Êulminskaya AA et al: Amylolytic activity and catalytic properties of IgM and IgG antibodies from patients with systemic lupus erythematosus. Human Antibodies, 2003; 12: 31-34
19. Li L, Paul S, Tyutyulkova S et al: Catalytic activity of anti-thyroglobulin antibodies. J Immunol, 1995; 154: 3328-32
20. Kalaga R, Li L, O'Dell JR, Paul S: Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis. J Immunol, 1995; 155: 2695-702
21. Thiagarajan P, Dannenbring R, Matsuura K et al: Monoclonal antibody light chain with prothrombinase activity. Biochemistry, 2000; 39: 6459-65
22. Lacroix-Desmazes S, Moreau A, Sooryanarayana A et al: Catalytic activity of antibodies against factor VIII in patients with hemophilia A. Nat Med, 1999; 5: 1044-47
23. Andrievskaia OA, Buneva VN, Naumov VA, Nevinsky GA: Catalytic heterogeneity of polyclonal RNA-hydrolyzing IgM from sera of patients with lupus erythematosus. Med Sci Monit, 2000; 6(3): 460-70
24. Saveliev AN, Ivanen DR, Kulminskaya AA et al: Amylolytic activity of IgM and IgG antibodies from patients with multiple sclerosis. Immunol Lett, 2003, 86: 291-97
25. Planque S, Bangale Y, Song XT et al: Ontogeny of Proteolytic Immunity: IgM serine proteases. J Biol Chem, 2004; 279: 1424-32
26. Nevinsky GA, Kanyshkova TG, Semenov DV et al: Secretory immunoglobulin A from healthy human mothers milk catalyzes nucleic acid hydrolysis. Appl Biochem Biotechnol, 2000; 83: 115-30
27. Semenov DV, Kanyshkova TG, Karotaeva NA et al: Catalytic nucleotide-hydrolyzing antibodies in milk and serum of clinically healthy human mothers. Med Sci Monit, 2004; 10(1): BR23-BR33
28. Nevinsky GA, Kit YY, Semenov DV, Buneva VN: Secretory immunoglobulin A from human milk catalyzes reaction of the milk proteins phosphorylation. Appl Biochem Biotechnol, 1998; 75: 77-91
29. Kit YY, Semenov DV, Nevinsky GA: Phosphorylation of different human milk proteins by human catalytic secretory immunoglobulin A. Biochem Mol Biol Intern, 1996; 39: 521-27
30. Savel'ev AN, Kanyshkova TG, Kulminskaya AA et al: Amylolytic activity of IgG and sIgA immunoglobulins from human milk. Clin Chim Acta, 2001; 314: 141-52
31. Buneva VN, Kudryavtseva AN, Dubrovskaya W et al: Dynamics of nuclease activity level from blood of pregnant and parturient women. Biochemistry (Moscow), 2003; 68: 890-900
32. Paul S: Mechanism and functional role of antibody catalysis. Appl Biochem Biotechnol, 1998; 75: 13-23
33. Kozyr AV, Kolesnikov AV, Aleksandrova ES et al: Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases. Appl Biochem Biotechnol, 1998; 75: 45-61
34. Dubrovskaya VV, Andryushkova AS, Kuznetsova IA et al: DNA-hydrolyzing antibodies from sera of autoimmune-prone MRL/MpJ-lpr mice. Biochemistry (Moscow), 2003; 68: 1081-88
35. Nevinsky GA, Breusov AA, Baranovskii AG et al: Effect of different drugs on the level of DNA-hydrolyzing polyclonal IgG antibodies in sera of patients with Hashimoto's thyroiditis and nontoxic nodal goiter. Med Sci Monit, 2001; 7(2): 201-11
36. Boiko AN, Favorova OO: Multiple sclerosis: molecular and cellular mechanisms. Mol Biol (Mosk), 1995; 29: 727-49
37. O'Connor KC, Bar-Or A, Hafler DA: Neuroimmunology of multiple sclerosis. J Clin Immunol, 2001; 21: 81-92
38. Archelos JJ, Storch MK, Hartung HP: The role of B cells and autoantibodies in multiple sclerosis. Ann Neurol, 2000; 47: 694-706
39. Hemmer B, Archelos JJ, Hartung HP: New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci, 2002; 3: 291-301
40. Cross AH, Trotter JL, Lyons J: B cells and antibodies in CNS demyelinating disease. J Neuroimmunol, 2001; 112: 1-14
41. Williamson RA, Burgoon MP, Owens GP et al: Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc Natl Acad Sci USA, 2001; 98: 1793-98
42. Ershova NA, Garmashova NV, Buneva VN et al: Association between DNA antibodies levels in the blood of patients with multiple sclerosis and clinical presentation of the disease. Zh Nevrol Psikhiatr Im SS Korsakova, 2003; Spec No 2: 25-33
43. Baranovskii AG, Kanyshkova TG, Mogelnitskii AS et al: Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA. Biochemistry (Moscow), 1998; 63: 1239-48
44. Baranovskii AG, Ershova NA, Buneva VN et al: Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis. Immunol Lett, 2001; 76: 163-67
45. Vanguri P, Lee E, Henkart P, Shin ML: Hydrolysis of myelin basic protein in myelin membranes by granzymes of large granular lymphocytes. J Immunol, 1993; 150: 2431-39
46. Ponomarenko NA, Durova OM, Vorobiev II et al: Catalytic antibodies in clinical and experimental pathology: human and mouse models. J Immunol Methods, 2002; 269: 197-211
47. Polosukhina DI, Kanyshkova T, Doronin BM et al: Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple sclerosis. J Cell Mol Med, 2004; 8: 359-68
48. Poser CM: The diagnosis of multiple sclerosis. Thieme-Stratton NY, 1984; 3-13
49. Kamholz J, de Ferra F, Pukkett C, Lazzarini R: Identification of three forms of human myelin basic protein by cDNA cloning. Proc Natl Acad Sci USA, 1986; 83: 4962-66
50. Deibler GE, Boud LF, Kies MW: Enzymatic and nonenzymatic degradation of myelin basic protein. Neurochem Research, 1984; 9: 1371-85
51. Enshtein E: The proteins of brain and cerebrospinal fluid in norm and pathology, Myr, 1988